论文信息 - Bortezomib-Doxorubicin-Dexamethasone (BDD) in Patients with Acute Light Chain Induced Renal Failure (ARF) in Multiple Myeloma (MM). Final Results of a Phase II Study. - 字舞流文

Bortezomib-Doxorubicin-Dexamethasone (BDD) in Patients with Acute Light Chain Induced Renal Failure (ARF) in Multiple Myeloma (MM). Final Results of a Phase II Study.

R. Greil | R. Hájek | H. Gisslinger | F. Keil | H. Ludwig | J. Thaler | N. Zojer | M. Egyed | Z. Adam | E. Tóthová | A. Lang | E. Autzinger